Pharma Penny Stock Under Rs 50 Jumps Over 5 Per Cent on April 03; Do you Have It?
From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent.
India's pharmaceutical industry received a major advantage as the Trump administration exempted pharmaceuticals from new reciprocal tariffs. This decision, embedded within the tariff regulations, protects a key Indian export sector, which relies on the U.S. for 30 per cent of its sales, from potential trade-related cost increases and ensures continued competitiveness.
Today, shares of Sigachi Industries Ltd jumped over 5 per cent to Rs 38.90 per share from its previous closing of Rs 36.91 per share. The company has a market cap of over Rs 1,200 crore and has delivered good profit growth of 25 per cent CAGR over the last 5 years.
Sigachi Industries Limited, a publicly traded pharmaceutical company listed on NSE and BSE, is a global leader in providing high-quality excipients, vitamin-mineral nutrient blends, APIs, and O&M services. With over 35 years of industry expertise, Sigachi has built a strong reputation as a trusted partner for pharmaceutical and nutraceutical companies worldwide. They specialize in innovative solutions for food stability, fortification, and nutrition, offering tailored blends of vitamins, minerals, and other ingredients to meet the evolving needs of consumers. By utilizing advanced technologies like blending, encapsulation, and spray drying, Sigachi empowers food manufacturers to create products with superior taste, quality, and nutritional value, contributing to a healthier and happier world.
DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, do download the service details here.
Recently, Sigachi Industries Limited and the Indian Navy (INS Kalinga) have forged a partnership to promote "Healthy Living" through the "Vizag Navy Marathon Promo cum Conditioning Programme," marked by a Memorandum of Understanding signed on March 10, 2025. This initiative, spearheaded by Amit Raj Sinha and Cmde SP Patel, will feature monthly fitness events, training sessions, and community engagement from March to October 2025 in Visakhapatnam, aiming to empower individuals to adopt healthier lifestyles and increase participation in public health initiatives. By combining their resources and influence, Sigachi Industries and the Indian Navy intend to cultivate a culture of health and wellness, reinforcing Sigachi's commitment to socially responsible initiatives that advance holistic well-being.
The company announced positive Quarterly Results (Q3FY25) and nine-month results (9MFY24). According to quarterly results, revenue increased by 26 per cent to Rs 139.42 crore, EBITDA increased by 45 per cent to Rs 35.19 crore and consolidated net profit increased by 33 per cent to Rs 21.35 crore in Q3FY25 compared to Q3FY24. In its nine-month results, revenue increased by 22 per cent to Rs 360.03 crore, EBITDA increased by 39 per cent to Rs 89.75 crore and consolidated PAT increased by 33 per cent to Rs 56.29 crore in 9MFY25 compared to 9MFY24.
From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent. Investors should keep an eye on this small-cap pharma stock.
Disclaimer: The article is for informational purposes only and not investment advice.